Analysts think NRXP stock price could increase by 823%
Jun 14, 2024, 6:29 AM
-27.30%
What does NRXP do
NRX Pharmaceuticals, Inc., a clinical-stage company based in Wilmington, Delaware, focuses on developing treatments for central nervous system disorders like suicidal depression and PTSD. Their key projects include NRX-101 for bipolar depression in Phase III trials and ZYESAMI for COVID-19 respiratory failure.
4 analysts think NRXP stock price will increase by 823.28%. The current median analyst target is $32.13 compared to a current stock price of $3.48. The lowest analysts target is $20.20 and the highest analyst target is $45.15.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.